Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2016
At a glance
- Drugs Afatinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms DARWIN1
- 19 Dec 2016 Status changed from not yet recruiting to recruiting.
- 08 Mar 2016 Planned initiation date changed from 1 Dec 2015 to 1 May 2016 as reported by ClinicalTrials.gov record.
- 14 Oct 2015 Planned initiation date changed from 1 Jun 2015 to 1 Dec 2015, according to ClinicalTrials.gov record.